Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 4473
  • 4474
  • 4475
  • …
  • ›
  • »

2026-02-25

Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ™

2026-02-25

Mithril Lidar Study Reveals 1.5 Km Trend And Historic Mines At La Dura Gold-Silver Project, Durango, Mexico

2026-02-25

Emergent Metals Corp. Reports High Grade Gold Intercept at West Santa Fe: 36.6 m Grading 3.11 g/t AuEq Including 10.7 M Grading 5.75 g/t AuEq

2026-02-25

Dine Brands Swings to Loss Despite Higher Revenue

2026-02-25

MGP Ingredients Declares $0.12 Quarterly Dividend

2026-02-25

Private Credit′s AI Woes Not Systemic, Brookfield′s Flatt Says

2026-02-25

Bank of Montreal Profit Rises With Lift in Revenue, Drop in Credit-Loss Provision

2026-02-25

Hiscox lifts dividend after third straight year of record profits

2026-02-25

International Personal Finance FY profits rise, backs improved BasePoint offer

2026-02-25

Jet2 maintains growth trajectory ahead of Gatwick launch

2026-02-25

Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis

2026-02-25

Dine Brands Global falls after sluggish quarter for Applebee′s

  • «
  • ‹
  • …
  • 4473
  • 4474
  • 4475
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies